GLP-1

All articles by GLP-1

Real Chemistry deploys IRIS to supply AI-supported insights on GLP-1 space
Real Chemistry deploys IRIS to supply AI-supported insights on GLP-1 space
Jack O'Brien
April 30, 2024
7:00 am

The first report from IRIS, the latest intelligence offering from Real Chemistry, delves into the power of GLP-1 influencers.

Why the obesity drug market is about to get a lot more crowded
Why the obesity drug market is about to get a lot more crowded
Marc Iskowitz
April 26, 2024
9:00 am

The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.

Currax Pharmaceuticals CEO says the GLP-1 conversation isn’t one-size-fits-all
Currax Pharmaceuticals CEO says the GLP-1 conversation isn’t one-size-fits-all
MM+M Staff
April 24, 2024
1:08 pm

Currax Pharmaceuticals CEO George Hampton talks about the ascendance of GLP-1 drugs and how weight loss drugs are changing the obesity narrative.

MediaRadar CEO: What the ‘enormous’ increase in GLP-1 ad spend means
MediaRadar CEO: What the ‘enormous’ increase in GLP-1 ad spend means
Jack O'Brien
April 8, 2024
1:43 pm

As for the go forward, MediaRadar CEO Todd Krizelman said he expects to see an expansion in terms of advertising spend for GLP-1 drugs.

Brand managers reflect on historic launch of Wegovy
Brand managers reflect on historic launch of Wegovy
Marc Iskowitz
April 8, 2024
11:16 am

Runaway demand — and an all-out attempt to slow it down. What was it like to launch the juggernaut that ignited the obesity treatment dynamic?

Currax Pharmaceuticals CEO: GLP-1 drugs lift entire weight loss category
Currax Pharmaceuticals CEO: GLP-1 drugs lift entire weight loss category
Jack O'Brien
April 4, 2024
12:53 pm

When Currax Pharmaceuticals CEO George Hampton evaluates the impact of GLP-1 drugs on the pharma industry, he is reminded of the old adage: a rising tide lifts all boats.

What are ‘Ozempic babies?’ Surprise pregnancy, GLP-1 connection, explained
What are ‘Ozempic babies?’ Surprise pregnancy, GLP-1 connection, explained
Lecia Bushak
March 29, 2024
2:02 pm

Women on TikTok recount their experiences with surprise pregnancies while taking Ozempic. Experts say the phenomenon may be linked to weight loss on GLP-1 drugs.

Wider payer coverage could give GLP-1 revolution a jolt
Wider payer coverage could give GLP-1 revolution a jolt
Marc Iskowitz
March 28, 2024
5:02 pm

Some payers have begun putting these GLP-1 treatments on formulary, as drug policy experts caution about financial strain.

GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
Marc Iskowitz
March 20, 2024
2:39 pm

With PD-1 drugs set to end their reign as top-selling drug class, the status quo is poised to shift in favor of GLP-1s.

In primetime special, Oprah delves into GLP-1 drugs, obesity-shaming
In primetime special, Oprah delves into GLP-1 drugs, obesity-shaming
Jack O'Brien
March 19, 2024
4:18 pm

The primetime special from Oprah Winfrey examined the rise of GLP-1 drugs like Ozempic and Mounjaro as well as the need to do away with obesity shaming.

  • From Our Partners